News

2015 Jan 16

Drug study sheds light on gastroesophageal adenocarcinoma

Manish Shah, M.D., director of gastrointestinal oncology, talks about a recent phase II study of mFOLFOX paired with the MET inhibitor onartuzumab for the treatment of metastatic, HER2-negative gastroesophageal adenocarcinoma. Read more

2015 Jan 16

Furman discusses treatment options for patients with CLL

Richard Furman, director of Weill’s Chronic Lymphocytic Leukemia Research Center, weighs in on debates about when and how to treat patients with CLL. Read more

2015 Jan 15

Graduate student has cultured an unexpected side passion: Fish

In the course of trying to contribute to cures for cancer, Sara DiNapoli has cultured an unexpected side passion: Fish. Read more

2015 Jan 15

A new paradigm: Precision medicine

Cancer: It’s personal, and not only on an emotional level, but a molecular one. Every patient's cancer is unique, driven by distinct biological factors. So, too, should every patient’s treatment. Read more

2015 Jan 14

Meyer investigators land two of six prestigious national awards

Himisha Beltran and Christopher Barbieri were awarded Challenge Awards from the Prostate Cancer Foundation, two of only six distributed nationwide. Read more

2014 Dec 18

New understanding of macrophage gene regulation could help control cancer

A new database that maps how cells regulate gene expression could provide strategies to stop tumor growth. Read more

2014 Dec 15

Molecular link discovered between prostate and breast cancer, suggesting new treatment approach for men's tumor

Prostate cancer can be driven by the same estrogen receptor responsible for the most common form of breast cancer. Read more

2014 Dec 12

Epigenetics research prompts hope for improved treatment of acute myeloid leukemia

Gail Roboz, director of the Leukemia Program, presented an educational platform discussing the introduction of epigenetic and personalized therapies targeting AML at the ASH Annual Meeting. Read more

2014 Dec 12

Researchers reveal key step in synthesis of DNA at chromosome ends

A new study by Neal Lue and colleagues clarifies how telomeres, the protective caps at the tips of our chromosomes, are made. Read more

2014 Dec 11

How DNA sequencing in sewers could detect disease outbreaks

Christopher Mason, assistant professor of computational and systems biomedicine, is creating a “Pathomap” of germs Read more

2014 Dec 08

Promising results for Lenalidomide-Rituximab treatment in mantle cell lymphoma

Jia Ruan, M.D., Ph.D., talks to OncLive about the results of a phase II study that show sustained remissions experienced by patients treated with the combination of lenalidomide and rituximab as initial treatment for mantle cell lymphoma (MCL). Read more

2014 Nov 21

New study sheds light on prostate cancer development

Researchers have discovered more information about an elusive part of our cells, which could lead to a better understanding of how prostate cancer develops. Read more

2014 Nov 06

Chen-Kiang honored with $600k V Foundation translational grant

Selina Chen-Kiang, Ph.D., was among 12 scientists selected from across the nation to receive a $600,000 award to promote translational cancer research. Read more

2014 Nov 05

Roboz discusses progress, challenges in AML

Gail J. Roboz, M.D., discusses the status of research into acute myeloid leukemia during a presentation at the 2014 Chemotherapy Foundation Symposium. Read more

2014 Oct 20

Cantley elected to the Institute of Medicine of the National Academies

Meyer Cancer Center Director Lewis C. Cantley receives one of the highest honors in the fields of health and medicine Read more

2014 Oct 07

Cancer research breakthrough for WCMC-Qatar

Researchers at Weill Cornell Medical College in Qatar have made a major step towards understanding why certain cancers often recur after they have been treated with conventional therapies. Read more

2014 Oct 02

Liquid biopsy project receives innovation award and funding

David Lyden’s blood test to isolate cancer released exosomes was one of six projects selected as winners of the inaugural Daedalus Fund for Innovation. Read more

2014 Sep 22

Target Practice: Precision approaches are a major advance in the treatment of blood cancers

A feature in Weill Cornell Medicine highlights some of the work being done by John Leonard, Leandro Cerchietti, Ari Melnick and others at the Meyer Cancer Center to tailor treatments to individual patients. Read more

2014 Sep 10

End-of-life care preferences: A promising target for reducing racial disparities in terminal cancer care

Race and ethnicity dramatically influence patients' end-of-life preferences, which affect the likelihood they will complete a do-not-resuscitate order. Read more

2014 Sep 04

The newest precision medicine tool: Prostate cancer organoids

Work by Andrea Shoner and his team has demonstrated that organ tissue derived from human prostate cancer tumors can be grown in the laboratory, giving researchers a new tool to test cancer drugs and personalize cancer treatment. Read more